Coronary artery disease (CAD) is one of the most important causes of death in Europe in both men and women [1]. According to the European Society of Cardiology (ESC) guidelines, the defi nition of acute coronary syndrome (ACS) includes unstable angina (UA), ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) [2, 3]. There are many gender differences among patients with CAD, including risk factors, clinical presentation and ACS outcomes [4]. Statistically women develop CAD ca. 10 years later than men [5], therefore this disease was believed to be 'a men's domain'. One of the reasons for this is the atheroprotective effect of estrogen [6]. However, some latest reports have concluded that mortality due to CAD is higher in women than in men [7], and that women with ACS have higher rates of in-hospital complications and risk of death than men [4]. Less specifi c symptoms of CAD in women [8] cause ABSTRACT Background. Coronary artery disease (CAD) is one of the most important causes of death in both men and women. There are many gender differences among patients with CAD, including risk factors and acute coronary syndrome (ACS) outcomes. The latest reports showed that mortality due to CAD is higher in women than in men. Cardiac biomarkers play an important role in risk stratifi cation and choice of treatment strategy in patients with ACS, however some of cardiac biomarkers show worse sensitivity and specifi city in women. Aim. The aim was to investigate the sex-related differences in patients with acute coronary syndrome and to compare their sex-related risk of in-hospital mortality. Material and Methods. Single-center study of patients diagnosed with ACS who underwent precutaneous coronary intervention (PCI). Patients were diagnosed and treated according to ESC Guidelines. Statistical analysis was performed using StatSoft Statistica. Results. Of the 297 patients included in this study, 32% were women and 68% were men. There were 26.94% STEMI patients, 22.22% NSTEMI patients and 50.84% unstable angina patients. Compared with males, females were signifi cant older (68.2 ± 10.6 vs. 64.8 ± 11.0; p = 0.0175). Levels of biomarkers of myocardial injury were signifi cantly lower in women: CK-MB (p = 0.0241), troponin I (p = 0.0417) and CK (p = 0.0035) than in men. Women were less frequently treated with PCI or CABG (p = 0.0016) but the in-hospital outcomes (cardiogenic shock, sudden cardiac arrest or cardiac death) were similar in both groups (p = 0.8557). Conclusions. Women with ACS were older and have higher incidence of non-ST-elevation ACS than men. In-hospital mortality show no signifi cant difference between genders. Women were less likely to receive invasive treatment.
Introduction
Coronary artery disease (CAD) is one of the most important causes of death in Europe in both men and women [1] . According to the European Society of Cardiology (ESC) guidelines, the defi nition of acute coronary syndrome (ACS) includes unstable angina (UA), ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) [2, 3] . There are many gender differences among patients with CAD, including risk factors, clinical presentation and ACS outcomes [4] . Statistically women develop CAD ca. 10 years later than men [5] , therefore this disease was believed to be 'a men's domain'. One of the reasons for this is the atheroprotective effect of estrogen [6] . However, some latest reports have concluded that mortality due to CAD is higher in women than in men [7] , and that women with ACS have higher rates of in-hospital complications and risk of death than men [4] . Less specifi c symptoms of CAD in women [8] cause signifi cant diagnostic diffi culties. Cardiac biomarkers, such as cardiac troponins and MB fraction of creatine kinase (CK-MB), being important indicators of myocardial injury [9] , play an important role in risk stratifi cation and choice of treatment strategy in patients with ACS. Blood tests for these biomarkers in women show worse sensitivity and specifi city than in men [10] . Because diagnosis and risk stratifi cation of ACS is more diffi cult in women, a multimarker approach may be appropriate in female population. Sex-related differences in patients with ACS require searching for a strategy providing better risk stratifi cation and aiding choice of treatment.
Aim
The aim of this study was to investigate sex-related differences in clinical status, biomarker profi le, echocardiographic parameters and treatment strategy in patients with ACS and to compare their sex-related risk of in-hospital mortality.
Material and Methods
This study analyzed data from a prospective single-center registry of patients with ACS. 297 consecutive patients were included; they were admitted to hospital between the 1 st January and 31 st December 2014 and diagnosed with ACS. All the patients were diagnosed and treated according to the ESC Guidelines [2, 3] . The exclusion criteria were end-stage renal disease, severe liver disease and pregnancy. On admission, the patients underwent physical examination, ECG and had blood collected for laboratory tests, and the investigators collected demographic data and medical history. 
Results
Of the 297 patients included in this study, 96 (32%) were women and 201 (68%) were men. There were 80 (27%) patients with STEMI, 66 (22%) with NSTEMI and 151 (51%) with UA. Men presented signifi cantly more frequently with STE-MI, and women with UA. Female sex was associated with a higher incidence of non-ST-elevation acute coronary syndrome (NSTE-ACS) (UA and NSTEMI) (82% vs. 69%, p = 0.0378). Incidence of NSTEMI was similar in both groups (Table 1) . Women were older and had signifi cantly higher systolic blood pressure on admission. They were more likely to have lower red blood cells count and hemoglobin level, and higher count of blood platelets. There were no signifi cant differences in body mass index (BMI), heart rate on admission, and comorbidities such as arterial hypertension Table 3) . Women had signifi cantly lower blood concentrations of troponin I, creatine kinase-myocardial band (CK-MB) and lower creatine kinase activity (CK); but there was no signifi cant difference in concentrations of CK-MB mass between both genders (Table 4 ). In detailed analysis of ischaemic cardiac enyzmes in separate groups of ACS patients, there were no signifi cant differences observed in levels of troponin, CK-MB mass, CK-MB, CK between men and women ( * mean values and SD BMI -body mass index; SBP -systolic blood pressure; HR adm -heart rate at admission;; RBC -red blood cells count; HGB -hemoglobin; PLT -platelet count; WBC -white blood cells count; ESR -erythrocyte sedimentation rate, Glc adm -glucose at admission.
Discussion
The hereby-presented analysis shows a number of interesting information referring to effect of gender on course and treatment of ACS. The main fi nding is that female sex was associated with a higher incidence of non-ST-elevation ACS and lower of ST-segment elevation acute coronary syndrome (STE ACS) than male gender. In-hospital mortality was not different between men and women despite lower levels of injury markers, lower prevalence of heart failure and higher ejection fraction in women. But women were less likely receiving invasive treatment. TnI -Cardiac Troponin I; CK-MBmass -mass concentration of creatine kinase-MB, CK-MB -creatine kinase-myocardial band; CK -creatine kinase. veys showed the prevalence of hypertension and diabetes mellitus with the same frequency in men and women [14] . Incidence of heart failure was lower in women, which is in opposite with the previous studies [12] . Comorbidities occur with similar frequency in both women and men, but other authors show that women have a greater number of comorbidities [15] . Usually there are modifi able risk factors for heart diseases, such as smoking, obesity, hypertension or hyperlipidemia. Differences between studies may mainly be due to different inclusion criteria, whether patients with confi rmed or suspected ACS were included. Referring to a recent study, heart rate may be an important prognostic factor [16] and may help in stratifi cation of risk [17] connected with incidence of ACS. We showed no signifi cant difference in heart rate on admission between men and women. It should be noted that heart rate on admission is considered one of the ACS prognostic factors.
There was no signifi cant difference between genders in BMI, whereas in other studies higher BMI correlated with higher occurrence of ACS and male gender [18] . Previous studies show the impact of obesity on the development of CAD appears to be greater in women than in men [19] . The Framingham Heart Study showed that obesity increased relative risk of CAD by 64% in women, as opposed to 46% in men [20] . Moreover other surveys showed that patients who have higher BMI have higher risk of STEMI than any other type of ACS, but also they have the same risk for in-hospital outcomes [21] . It was also shown that obese patients, especially men, have better prognosis after ACS [22] .
We found no difference in mortality between genders. Numerous investigators observed higher early mortality after STEMI in women than in men [21] . In comparison, another analysis showed no differences in early (30 days) mortality in STEMI in women versus in men [23] ; and a similar incidence of in-hospital MACE was demonstrated also in NSTE-ACS [13] . Long-term mortality was not taken under consideration in our study. What is more, according to other studies, in-hospital outcomes are very rare in NSTEMI patients. Several studies showed that mortality after NSTE-ACS is similar in both men and women [13] . Sex-related differences in early mortality after MI are the topics of numerous studies. After MI, younger women, but not older women, have higher mortality during hospitalization than men of the same age [5] . The younger patients were, the higher the risk of death of female patients was compared to males [5] .
We noticed also that women underwent coronary revascularization relatively rarely compare to men, as it was observed in other studies [13] . This observation may be consistent with lower biomarkers level and lower risk-baseline characteristics in women. The majority of women from investigated population were treated conservatively. Other trials explain, that different manifestations of CAD in women are associated with their smaller coronary arteries, higher coronary blood flow, and higher endothelial shear stress, which have major effects on endothelial function and resistance to coronary atherosclerosis [24] . In women complex interactions of focal stenosis, diffuse epicardial coronary narrowing, related endothelial shear stress, and microvascular dysfunction often make diagnostic process diffi cult by use of standard noninvasive or invasive technologies [24] .
Several studies examined relationship between troponin concentration and gender, and showed women to have lower concentrations of troponins [14] ; these results are consistent with our fi ndings. However in detailed analysis of every ACS group there were no differences between men and women in level of cardiac biomarkers. According to another survey [25] , predictive value of troponin concentration is greater in women than in men, thus knowing the differences and establishing cut-off points separating women and men might be useful. The high sensitivity troponin assay with sex specifi c diagnostic thresholds may double the diagnosis of myocardial infarction in women and identify those at high risk of reinfarction or death [14] . The risk of under-diagnosing of myocardial infarction in women can contribute to inequalities in the management and treatment of myocardial infarction. In clinical practice it is important, to take into consideration, differences among genders to improve diagnosis and treatment strategy in both men and women.
Limitations of the study
This was prospective single-center registry of patients with ACS, so the number of patients is not very high.
Conclusion
Female sex was associated with a higher incidence of non-ST-elevation ACS and lower of ST-elevation ACS than male gender. In-hospital mortality was not different between men and women despite lower levels of heart injury markers, lower prevalence of heart failure, and higher ejection fraction in women. Women were less likely to receive invasive treatment.
